Check out the companies making the biggest moves midday: Alkermes — The biotech company dropped 9% as traders weighed phase 2 trial results for its ALKS...
A recent decision by the Securities and Exchange Commission to begin allowing fund companies to create ETF shares classes of traditional mutual funds is expected to...
(These are the market notes on today’s action by Mike Santoli, CNBC’s Senior Markets Commentator. See today’s video update from Mike above.) In last Friday’s closing...
(These are the market notes on today’s action by Mike Santoli, CNBC’s Senior Markets Commentator.) A fourth day of erratic action and failed rally attempts gave...
